Russell Frank Company’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-23,766
Closed -$1.09M 3174
2015
Q1
$1.09M Sell
23,766
-10,095
-30% -$302K ﹤0.01% 2098
2014
Q4
$812K Buy
33,861
+30,039
+786% +$677K ﹤0.01% 2246
2014
Q3
$96K Buy
3,822
+1,495
+64% +$37.1K ﹤0.01% 2668
2014
Q2
$56K Buy
+2,327
New +$59.8K ﹤0.01% 2699
2013
Q4
Sell
-20,579
Closed -$538K 3358
2013
Q3
$538K Sell
20,579
-4,396
-18% -$110K ﹤0.01% 2460
2013
Q2
$549K Buy
+24,975
New +$547K ﹤0.01% 2298

Russell Frank Company's HPTX Position: Q2 2015 in Review

Russell Frank Company sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 23,766 shares — an estimated $1.09M sold.

Russell Frank Company first reported a position in HPTX in Q2 2013 and held it in 6 quarters. The position peaked at $1.09M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Russell Frank Company reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Russell Frank Company sold 23,766 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $1.09M.
  • Russell Frank Company first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Russell Frank Company's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.09M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Russell Frank Company's 13F filing for Q2 2015, filed 13 Aug 2015.